quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 23, 2026

Assessing American Express (NYSE:AXP) Valuation After Recent Share Price Pullback

View original at finance.yahoo.com
Assessing American Express (NYSE:AXP) Valuation After Recent Share Price Pullback Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • American Express stock is down approximately 6% over the past month

    60% confidence
  • American Express stock is down approximately 10% over the past 3 months

    60% confidence
  • The fair value of American Express stock sits at $308.19 compared with the last close of $311.78, making the stock approximately 1% overvalued

    60% confidence
  • Continuous enhancements to the Membership Model are expected to fuel the earnings power of the American Express core business

    60% confidence
  • American Express share price is down 16.35% year to date

    60% confidence
  • AXP fair value is classified as ABOUT RIGHT at $308.19 versus last close of $311.78

    60% confidence
  • American Express 5-year total shareholder return is 106.88%

    60% confidence
  • The AXP fair value narrative leans heavily on card fee momentum, product refreshes, and acquisition-driven scale

    60% confidence
  • Acquisitions of Resy and planned acquisitions of Tock and Rooam aim to expand American Express's dining portfolio and digital offerings, enhancing their value proposition

    60% confidence
  • American Express plans to refresh approximately 40 products globally, which is expected to drive new card acquisitions and customer engagement

    60% confidence
  • American Express 1-year total shareholder return is 10.46%

    60% confidence
  • American Express has been driving strong new card acquisitions, which is a key driver of their business

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com